Sign in

CIK 0000872589

  • Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
133444607
Phone
+1 914-847-7000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
  1. 4 Open-market sale Director sold 100 shares at an average $483.60 ($48,360)
  2. 4 Grant or award Director acquired 248 shares (grant or award)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Shares withheld for taxes President and Chief Scientific gave up 216,810 shares (to pay taxes)
  6. 4 Grant or award EVP Research acquired 10,214 shares (grant or award)
  7. 4 Grant or award Director acquired 2,439 shares (grant or award)
  8. 4 Grant or award EVP & General Mgr Industrial O acquired 6,930 shares (grant or award)
  9. 4 Grant or award SVP Commercial acquired 3,075 shares (grant or award)
  10. 4 Grant or award EVP Research and Development acquired 1,688 shares (grant or award)
  11. 4 Grant or award VP Controller acquired 2,719 shares (grant or award)
  12. 4 Grant or award EVP Finance CFO acquired 1,930 shares (grant or award)
  13. 4 Grant or award EVP General Counsel and Secret acquired 1,930 shares (grant or award)
  14. 4 Open-market sale Director sold 100 shares at an average $520.48 ($52,048)
  15. 4 Open-market sale EVP Research sold 6,628 shares at an average $542.73 ($3,597,188)
  16. 4 Exercise or conversion Director acquired 11 shares (option exercise)
  17. 4 Open-market sale Director sold 100 shares at an average $548.54 ($54,854)
  18. 4 Exercise or conversion EVP Research acquired 5,185 shares (option exercise)
  19. 4 Open-market sale Director sold 9,212 shares at $600.00 ($5,527,200)
  20. 4 Open-market sale SVP Commercial sold 2,000 shares at an average $606.08 ($1,212,150)

Page 23 of 77 · 1,533 filings